Antibody Therapeutics Patients First!

공지사항


번호 제목 작성자 작성일 조회
16   PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.   관리자   2018-08-06   3,713  
15   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017.   관리자   2018-08-06   311  
14   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod   관리자   2018-08-06   294  
13   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017.   관리자   2018-08-06   298  
12   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial at 2017 Bio International Convention in San Diego on June 19-22, 2017.   관리자   2018-08-06   317  
11   Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017.]   관리자   2018-08-06   308  
10   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at BIO LOGISTICS WORLD KOREA in Seoul on May 23-24, 2017.   관리자   2018-08-06   298  
9   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an expert of MAB working group of EDQM observer representing Republic of Korea.   관리자   2018-08-06   306  
8   Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an officer for Bio at the Med term Strategy and planning for pharma industry.]   관리자   2018-08-06   417  
7   Dr. Jin-San Yoo, CEO of PharmAbcine will be awarded for the contribution of Health-Medical by KHIDI President on April 13th, 2017.   관리자   2018-08-06   308